Taro Pharmaceutical
TARO
#5182
Rank
โ‚น149.64 B
Marketcap
โ‚น3,982
Share price
0.00%
Change (1 day)
13.02%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): โ‚น101.03

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is โ‚น113.05. an increase over its 2022 EPS that were of โ‚น113.05.

EPS history for Taro Pharmaceutical from 2011 to 2023

Annual EPS

Year EPS Change
2023โ‚น113.050%
2022โ‚น113.052950%
2021โ‚น3.71-100.51%
2020-โ‚น732.94-222.45%
2019โ‚น598.58-18.02%
2018โ‚น730.1653.01%
2017โ‚น477.20-55.95%
2016โ‚น1,083-13.41%
2015โ‚น1,25136.92%
2014โ‚น913.6337.71%
2013โ‚น663.4521.15%
2012โ‚น547.6244.15%
2011โ‚น379.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น618.95 447.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น486.47 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น65.79-41.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.02-18.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น266.62 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น41.70-63.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel